| | | |   | | | | By Ed Silverman The FDA inspected Valisure facilities after a stretch in which the company openly pushed the agency to do more to test drugs for impurities. Read More | | By Elaine Chen Patrick Sison/AP The weight-loss effects of a new type of diabetes drug is causing rippling shortages, along with debate over who deserves access. Read More | | By Jason Mast Courtesy Charité A line of drugs that has transformed one deadly rare disease could moonlight as a treatment for a far more common one, pneumonia. Read More | | Sponsored Insight by Brunswick Healthcare communications: The bar is higher than ever The pandemic has made everyone on the planet a health information consumer, heightening the demands on healthcare companies to develop and deliver timely, practical information. These companies also need to communicate with a much larger set of audiences, not just industry insiders and experts. Brunswick helps healthcare companies navigate this new, more demanding landscape, by combining our deep sector knowledge with our understanding of the issues and messages that matter to innovators, investors, patients, providers, and the public. Learn about the company’s healthcare practice and how they can help you tell your best story. | | By Damian Garde Adobe An investigative medicine from Prometheus Biosciences met its goals in a pair of Phase 2 studies for patients with inflammatory bowel disease. Read More | | By John Wilkerson Milken Institute FDA Commissioner Robert Califf said the food side of the agency needs more attention Wednesday at a Milken Institute conference. Read More | |
No comments